Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of Simnotrelvir/Ritonavir in Adults with COVID-19
NCT05369676Phase 2Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simnotrelvir in coronavirus disease 2019 (COVID-19), sponsored by Simcere Pharmaceutical Group. Started May 2022; status: completed.
02
Drugs
simnotrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05369676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05369676.